Literature DB >> 32090048

Complications of intrastromal bevacizumab injection in lamellar keratoplasty.

Mohammad Soleimani1, Ahad Shahbazi1, Nader Mohammadi1, Seyed Ali Tabatabaei1.   

Abstract

Entities:  

Year:  2020        PMID： 32090048      PMCID： PMC7013780          DOI： 10.18240/ijo.2020.02.22

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  10 in total

Review 1.  Corneal neovascularization.

Authors:  J H Chang; E E Gabison; T Kato; D T Azar
Journal:  Curr Opin Ophthalmol       Date:  2001-08       Impact factor: 3.761

2.  Subconjunctival Bevacizumab Injection Impairs Corneal Innervations and Epithelial Wound Healing in Mice.

Authors:  Muchen Dong; Guohu Di; Xiaoping Zhang; Qingjun Zhou; Weiyun Shi
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-03-01       Impact factor: 4.799

Review 3.  Management of high-risk corneal transplantation.

Authors:  Antonio Di Zazzo; Ahmad Kheirkhah; Tulio B Abud; Sunali Goyal; Reza Dana
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

4.  Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization.

Authors:  Yoo C Kim; Hans E Grossniklaus; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-11       Impact factor: 4.799

5.  [Management of corneal neovascularization prior to corneal transplantation: Report of 112 cases].

Authors:  S Belghmaidi; I Hajji; W Ennassiri; R Benhaddou; T Baha Ali; A Moutaouakil
Journal:  J Fr Ophtalmol       Date:  2016-06-17       Impact factor: 0.818

6.  Herpetic epithelial keratitis after intravitreal injection of bevacizumab (avastin).

Authors:  Mohammad Reza Khalili; Morteza Mehdizadeh; Morsal Mehryar
Journal:  Cornea       Date:  2009-04       Impact factor: 2.651

Review 7.  Therapeutic approaches for corneal neovascularization.

Authors:  Sepehr Feizi; Amir A Azari; Sharareh Safapour
Journal:  Eye Vis (Lond)       Date:  2017-12-10

8.  Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells.

Authors:  Patrick R Merz; Nina Röckel; Seda Ballikaya; Gerd U Auffarth; Ingo Schmack
Journal:  BMC Ophthalmol       Date:  2018-12-11       Impact factor: 2.209

9.  Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes.

Authors:  Belghmaidi Sarah; Hajji Ibtissam; Baali Mohammed; Soummane Hasna; Moutaouakil Abdeljalil
Journal:  J Ophthalmol       Date:  2016-08-17       Impact factor: 1.909

Review 10.  Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment: Systematic review and meta-analysis.

Authors:  Shi-Tong Huang; Bi-Shan Tian; Ou Xiao; Yong-Juan Yang; Shi-You Zhou
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.